The Cancer Letter

Inside information on cancer research and drug development

Vol.
35
No.
3
March 30, 2012Mar 30, 2012
Free
DOWNLOAD THE PDF

Committee Unblinds Phase III Zytiga Study

USPSTF and ACS Recommend Less Frequent Cervical Cancer Screenings and Pap Smears

Tobacco Control and Prevention Saved 795,000 Lives Between 1975-2000, Study Shows

Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

Study: Freezing Secondary Tumors Helpful in Metastatic Breast Cancer

Women Who Received CMF Chemotherapy Score Lower On Cognitive Skill Exams

Three Studies Demonstrate Oncotype DX Test Effectiveness

ACG Highlights Link Between Obesity and Colorectal Cancer

Olaparib Study Demonstrates No Changes In Overall Survival

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

Trials Approved by NCI CTEP For the Month of March

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account